In a groundbreaking medical feat, artificial intelligence guided doctors in Bengaluru to safely perform a complex lung biopsy ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

Results reported for Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis. Company plans to meet with the FDA to ...

More than 28% of lung cancers were detected early, when survival rates are better — a 12% improvement over five years. Also, ...

Maryland residents can expect above-average treatment and survival rates for lung cancer, according to an American Lung ...

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

University of Texas at Dallas researchers have developed biosensor technology that, when combined with artificial ...

Discover Biodesix's Q3 2025 earnings: 20% revenue growth, expanding primary care adoption, and improved margins.

Thrombectomy System for the removal of blood clots from the lungs MENLO PARK, Calif., Nov. 3, 2025 /PRNewswire/ -- Dr. Andrew Klein, ENGULF National Co-Principal Investigator at Piedmont Hospital in ...

INTEGRIS Health did just that, moving him from scan to surgery in only 10 days. Surgeons removed an entire lobe of his lung, ...

Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascul ...